UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~February~~January 130, 2023

Cann American Corp

(Exact name of registrant as specified in its charter)

Wyoming	000-53712	84-3208139
(State or Other Jurisdiction	(Commission	(I.R.S. Employer
of Incorporation)	File Number)	Identification No.)

~~320~~75 Union ~~Santana Drive #C~~Ave., ~~Cloverdale~~Rutherford, ~~CA 95425~~NJ 07070

(Address of Principal Executive Offices) (Zip Code)

(~~770~~551) ~~866~~285-~~6250~~4350

(Registrant’s telephone number, including area code)

~~N/A~~320 Santana Drive #C, Cloverdale, CA 95425

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
N/A	N/A	N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5 1.0201 ~~Departure~~Entry ofinto ~~Directors~~a orMaterial ~~Certain~~Definitive ~~Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Agreement.

On ~~February~~January 130, 2023, ~~Jason Black resigned as director and from all offices of~~ the Company. Inentered ~~consideration of severance to Mr. Black~~into ~~the~~a ~~Company~~Binding ~~divested~~Letter ~~its~~of ~~remaining~~Intent ~~subsidiary, Cannequipt LLC, and assigned its sole control~~ to ~~Mr.~~acquire ~~Black.~~Prodigy ~~The~~Stem Company also assigned its loan agreements in "Cannagram" to Mr. Black. The Company has retained all ownership and rights to the "C-Juice" lines of CBD and Delta 8 products. The Company has also retained its hemp farming lease agreement in GlencoeCell, ~~Oklahoma. On~~LLC ~~February 1, 2023, Jason Tucker was appointed~~ as ~~Director,~~a ~~President,~~wholly ~~CEO,~~owned ~~Secretary~~subsidiary ~~and Treasurer~~ of the Company. Mr. Tucker has 18 years of experience in Business Development and Project Management. From December of 2020 to October of 2021 Mr. Tucker was CEO of General Environmental Management, Inc. (GEVI), where Mr. Tucker oversaw its successful audit and return to current reporting with the SEC after a decade of dormancy.

~~SIGNATURES~~Item 2.01 Completion of Acquisition or Disposition of Assets.

~~Pursuant to~~On ~~the~~March ~~requirements~~1, of2023, the ~~Securities~~Company ~~Exchange~~completed ~~Act~~the acquisition of ~~1934~~Prodigy Stem Cell, ~~the~~LLC ~~Registrant~~as ~~has~~a ~~duly caused~~wholly ~~this~~owned ~~report~~subsidiary. toProdigy beStem ~~signed~~Cell, onLLC ~~its~~is ~~behalf~~a byNew ~~the~~Jersey ~~undersigned~~based company focused on sales, ~~hereunto~~marketing, ~~duly~~and consulting ~~authorized~~for regenerative medicines.

~~Cann~~Item 5.02 ~~American~~Departure ~~Corp~~of ~~By:~~Directors ~~/s/~~or ~~Jason~~Certain ~~Tucker~~Officers; ~~Jason~~Election ~~Tucker~~of ~~CEO~~Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

~~Date: February~~On 6March 1, 2023, the Company appointed Peter Caruso as a Director of the Company. Mr. Caruso has over 20 years of business development experience and is the Founder of Prodigy Stem Cell, LLC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	Cann American Corp

	By:	/s/ Jason Tucker
		Jason Tucker CEO

Date: March 16, 2023

Filing Compare · Cann American Corp.